CAR-T Cell Therapy: From the Bench to the Bedside

被引：22

作者：

Golubovskaya, Vita ^{[1
]}

机构：

[1] Promab Biotechnol, 2600 Hilltop Dr, Richmond, CA 94806 USA

来源：

CANCERS | 2017年 / 9卷 / 11期

关键词：

CANCER;

D O I：

10.3390/cancers9110150

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 12 条

[1] Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events [J].

Anwar, Sidra ;

Tan, Wei ;

Hong, Chi-Chen ;

Admane, Sonal ;

Dozier, Askia ;

Siedlecki, Francine ;

Whitworth, Amy ;

DiRaddo, Ann Marie ;

DePaolo, Dawn ;

Jacob, Sandra M. ;

Ma, Wen Wee ;

Miller, Austin ;

Adjei, Alex A. ;

Dy, Grace K. .

CANCERS, 2017, 9 (07)

[2]

Beitz J, 1996, J Natl Cancer Inst Monogr, P7

[3] CAR T cells: driving the road from the laboratory to the clinic [J].

Cheadle, Eleanor J. ;

Gornall, Hannah ;

Baldan, Vania ;

Hanson, Vivien ;

Hawkins, Robert E. ;

Gilham, David E. .

IMMUNOLOGICAL REVIEWS, 2014, 257 (01) :91-106

[4] Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia [J].

Davila, Marco L. ;

Riviere, Isabelle ;

Wang, Xiuyan ;

Bartido, Shirley ;

Park, Jae ;

Curran, Kevin ;

Chung, Stephen S. ;

Stefanski, Jolanta ;

Borquez-Ojeda, Oriana ;

Olszewska, Malgorzata ;

Qu, Jinrong ;

Wasielewska, Teresa ;

He, Qing ;

Fink, Mitsu ;

Shinglot, Himaly ;

Youssif, Maher ;

Satter, Mark ;

Wang, Yongzeng ;

Hosey, James ;

Quintanilla, Hilda ;

Halton, Elizabeth ;

Bernal, Yvette ;

Bouhassira, Diana C. G. ;

Arcila, Maria E. ;

Gonen, Mithat ;

Roboz, Gail J. ;

Maslak, Peter ;

Douer, Dan ;

Frattini, Mark G. ;

Giralt, Sergio ;

Sadelain, Michel ;

Brentjens, Renier .

SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)

[5] CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth [J].

Golubovskaya, Vita ;

Berahovich, Robert ;

Zhou, Hua ;

Xu, Shirley ;

Harto, Hizkia ;

Li, Le ;

Chao, Cheng-Chi ;

Mao, Mike Ming ;

Wu, Lijun .

CANCERS, 2017, 9 (10)

[6] Therapeutic Potential of T Cell Chimeric Antigen Receptors (CARs) in Cancer Treatment: Counteracting Off-Tumor Toxicities for Safe CAR T Cell Therapy [J].

Gross, Gideon ;

Eshhar, Zelig .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56, 2016, 56 :59-+

[7] Most Do, but Some Do Not: CD4+CD25- T Cells, but Not CD4+CD25+ Treg Cells, Are Cytolytic When Redirected by a Chimeric Antigen Receptor (CAR) [J].

Hombach, Andreas A. ;

Abken, Hinrich .

CANCERS, 2017, 9 (09)

[8] Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM) [J].

Klampatsa, Astero ;

Haas, Andrew R. ;

Moon, Edmund K. ;

Albelda, Steven M. .

CANCERS, 2017, 9 (09)

[9] Designing CAR T cells for glioblastoma [J].

Maus, Marcela V. .

ONCOIMMUNOLOGY, 2015, 4 (12)

[10] Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia [J].

Porter, David L. ;

Hwang, Wei-Ting ;

Frey, Noelle V. ;

Lacey, Simon F. ;

Shaw, Pamela A. ;

Loren, Alison W. ;

Bagg, Adam ;

Marcucci, Katherine T. ;

Shen, Angela ;

Gonzalez, Vanessa ;

Ambrose, David ;

Grupp, Stephan A. ;

Chew, Anne ;

Zheng, Zhaohui ;

Milone, Michael C. ;

Levine, Bruce L. ;

Melenhorst, Jan J. ;

June, Carl H. .

SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (303)

← 1 2 →